The DOI matches its Crossref record; 43 of the 45 references it cites were found in a registry or an index.
Underestimation of liver‐related mortality in the United States
Open accessAbstract
Background & aims According to the National Center for Health Statistics (NCHS), chronic liver disease and cirrhosis is the 12(th) leading cause of death in the United States. However, this single descriptor might not adequately enumerate all deaths from liver disease. The aim of our study was to update data on liver mortality in the United States.Methods Mortality data were obtained from the Rochester Epidemiology Project (1999-2008) and the National Death Registry (1979-2008). Liver-specific mortality values were calculated. In contrast to the narrow NCHS definition, updated liver-related causes of death included other specific liver diagnoses (eg, hepatorenal syndrome), viral hepatitis, and hepatobiliary cancers.Results The Rochester Epidemiology Project database contained information on 261 liver-related deaths, with an age- and sex-adjusted death rate of 27.0/100,000 persons (95% confidence interval: 23.7-30.3). Of these, only 71 deaths (27.2%) would have been captured by the NCHS definition. Of cases for which viral hepatitis or hepatobiliary cancer was the cause of death, 96.9% and 94.3% had liver-related immediate causes of death, respectively. In analysis of data from the National Death registry (2008), use of the updated definition increased liver mortality by >2-fold (from 11.7 to 25.7 deaths/100,000, respectively). Using NCHS definitions, liver-related deaths decreased from 18.9/100,000 in 1979 to 11.7/100,000 in 2008-a reduction of 38%. However, using the updated estimate, liver-related deaths were essentially unchanged from 1979 (25.8/100,000) to 2008 (25.7/100,000). Mortality burden was systematically underestimated among non-whites and persons of Hispanic ethnicity.Conclusions Based on analyses of the Rochester Epidemiology Project and National Death databases, liver-related mortality has been underestimated during the past 2 decades in the United States.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“However, evidence to support integrated behavioral health for patients with chronic liver disease (CLD) is limited.4”
From A Behavioral Health Program for Alcohol Use Disorder, Substance Abuse, and Depression in Chronic Liver Disease (2019) · cites this paper as [4]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
El-Serag, H. B. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1001683 · Cited by 3,529
Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
El‐Serag, H. B. (2012) · Gastroenterology · doi:10.1053/j.gastro.2011.12.061 · Cited by 3,384
Chronic hepatitis B: Update 2009 #
Lok, A. S.-F., & McMahon, B. J. (2009) · Hepatology · doi:10.1002/hep.23190 · Cited by 2,836
D'Amico, G., Garcia-Tsao, G., & Pagliaro, L. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2005.10.013 · Cited by 2,687
Burden of Gastrointestinal Disease in the United States: 2012 Update
Peery, A. F., Dellon, E. S., Lund, J. L., Crockett, S. D., McGowan, C., Bulsiewicz, W. J., Gangarosa, L. M., Thiny, M. T., Stizenberg, K., Morgan, D. R., et al. (2012) · Gastroenterology · doi:10.1053/j.gastro.2012.08.002 · Cited by 2,010
History of the Rochester Epidemiology Project
Melton, L. J. (1996) · Mayo Clinic Proceedings · doi:10.4065/71.3.266 · Cited by 1,443
Arvaniti, V., D’Amico, G., Fede, G., Manousou, P., Tsochatzis, E. A., Pleguezuelo, M., & Burroughs, A. K. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.019 · Cited by 1,179
Charlton, M., Burns, J. M., Pedersen, R. A., Watt, K. D. S., Heimbach, J. K., & Dierkhising, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.06.061 · Cited by 1,115
Younossi, Z. M., Stepanova, M., Afendy, M., Fang, Y. H., Younossi, Y., Mir, H., & Srishord, M. K. (2011) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2011.03.020 · Cited by 1,072
Hepatocellular carcinoma: Recent trends in the United States
El‐Serag, H. B. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.013 · Cited by 971
Flagged first, then by citations
2 of the 45 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Burden of liver diseases in the world
Asrani, S. K., Devarbhavi, H., Eaton, J., & Kamath, P. S. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2018.09.014 · Cited by 3,783
Self-citationSepanlou, S. G., Safiri, S., Bisignano, C., Ikuta, K. S., Merat, S., Saberifiroozi, M., Poustchi, H., Tsoi, D., Colombara, D. V., Abdoli, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30349-8 · Cited by 1,714
Contemporary Epidemiology of Chronic Liver Disease and Cirrhosis
Moon, A. M., Singal, A. G., & Tapper, E. B. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.07.060 · Cited by 1,200
Burden of Gastrointestinal, Liver, and Pancreatic Diseases in the United States
Peery, A. F., Crockett, S. D., Barritt, A. S., Dellon, E. S., Eluri, S., Gangarosa, L. M., Jensen, E. T., Lund, J. L., Pasricha, S., Runge, T. M., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.045 · Cited by 993
Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study
Tapper, E. B., & Parikh, N. D. (2018) · BMJ · doi:10.1136/bmj.k2817 · Cited by 858
Pathogenesis of liver cirrhosis
Zhou, W.-C. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7312 · Cited by 664
Singh, S., Venkatesh, S. K., Wang, Z., Miller, F. H., Motosugi, U., Low, R. N., Hassanein, T., Asbach, P., Godfrey, E. M., Yin, M., et al. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.09.046 · Cited by 549
Global epidemiology of alcohol-associated cirrhosis and HCC: trends, projections and risk factors
Huang, D. Q., Mathurin, P., Cortez-Pinto, H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-022-00688-6 · Cited by 553
Rungratanawanich, W., Qu, Y., Wang, X., Essa, M. M., & Song, B.-J. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00561-7 · Cited by 411
Mandorfer, M., Bota, S. I., Schwabl, P., Bucsics, T., Pfisterer, N., Kruzik, M., Hagmann, M., Blacky, A., Ferlitsch, A., Sieghart, W., et al. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.03.005 · Cited by 376
Singh, S., Fujii, L. L., Murad, M. H., Wang, Z., Asrani, S. K., Ehman, R. L., Kamath, P. S., & Talwalkar, J. A. (2013) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2013.07.034 · Cited by 353
Self-citationSetiawan, V. W., Stram, D. O., Porcel, J., Lu, S. C.-L., Marchand, L. L., & Noureddin, M. (2016) · Hepatology · doi:10.1002/hep.28677 · Cited by 302
Singh, S., Muir, A. J., Dieterich, D. T., & Falck-Ytter, Y. T. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.03.016 · Cited by 268
Trends in the Burden of Chronic Liver Disease Among Hospitalized US Adults
Hirode, G., Saab, S., & Wong, R. J. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.1997 · Cited by 246
The balancing act of the liver: tissue regeneration versus fibrosis
Cordero-Espinoza, L., & Huch, M. (2018) · Journal of Clinical Investigation · doi:10.1172/jci93562 · Cited by 233
Kim, D., Li, A. A., Perumpail, B. J., Gadiparthi, C., Kim, W. K., Cholankeril, G. T., Glenn, J. S., Harrison, S. A., Younossi, Z. M., & Ahmed, A. (2018) · Hepatology · doi:10.1002/hep.30161 · Cited by 211
Self-citationMak, L., Liu, K., Chirapongsathorn, S., Yew, K. C., Tamaki, N., Rajaram, R. B., Panlilio, M. T., Lui, R. N.-S., Lee, H. W., Lai, J. C., et al. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00967-4 · Cited by 206
Julien, J., Ayer, T., Bethea, E. D., Tapper, E. B., & Chhatwal, J. (2020) · The Lancet Public Health · doi:10.1016/s2468-2667(20)30062-1 · Cited by 178
Intelligent Model to Predict Early Liver Disease using Machine Learning Technique
Ghazal, T. M., Rehman, A. U., Saleem, M. A., Ahmad, M., Ahmad, S., & Mehmood, F. (2022) · International Conference on Business Analytics for Technology and Security (ICBATS) · doi:10.1109/icbats54253.2022.9758929 · Cited by 166
Reversal of liver fibrosis: From fiction to reality
Zoubek, M. E., Trautwein, C., & Strnad, P. (2017) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2017.04.005 · Cited by 162
Prognosis of Patients with Cirrhosis and AKI Who Initiate RRT
Allegretti, A. S., Parada, X. F. V., Eneanya, N. D., Gilligan, H. M., Xu, D., Zhao, S. J., Dienstag, J. L., Chung, R. T., & Thadhani, R. (2017) · Clinical Journal of the American Society of Nephrology · doi:10.2215/cjn.03610417 · Cited by 160
Reducing the Global Burden of Alcohol‐Associated Liver Disease: A Blueprint for Action
Asrani, S. K., Mellinger, J. L., Arab, J. P., & Shah, V. H. (2020) · Hepatology · doi:10.1002/hep.31583 · Cited by 163
Self-citationYounossi, Z. M., Stepanova, M., Marcellin, P., Afdhal, N. H., Kowdley, K. V., Zeuzem, S., & Hunt, S. (2015) · Hepatology · doi:10.1002/hep.27724 · Cited by 138
The changing role of beta-blocker therapy in patients with cirrhosis
Ge, P. S., & Runyon, B. A. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.09.016 · Cited by 133
Brady, C. W. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i25.7613 · Cited by 129
Asrani, S. K., Kouznetsova, M., Ogola, G., Taylor, T. J., Masica, A. L., Pope, B., Trotter, J. F., Kamath, P. S., & Kanwal, F. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.05.032 · Cited by 122
Self-citationUnderstanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Russ, T. C., Kivimäki, M., Morling, J. R., Starr, J. M., Stamatakis, E., & Batty, G. D. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.02.004 · Cited by 110
Non-invasive detection of liver fibrosis: MR imaging features vs. MR elastography
Venkatesh, S. K., Yin, M., Takahashi, N., Glockner, J. F., Talwalkar, J. A., & Ehman, R. L. (2015) · Abdominal Imaging · doi:10.1007/s00261-015-0347-6 · Cited by 108
Presentation and complications associated with cirrhosis of the liver
Poordad, F. F. (2015) · Current Medical Research and Opinion · doi:10.1185/03007995.2015.1021905 · Cited by 102
Zhao, L., Zhang, X., Coday, M., Garcia, D. O., Li, X., Mossavar‐Rahmani, Y., Naughton, M. J., Lopez‐Pentecost, M., Saquib, N., Shadyab, A. H., et al. (2023) · JAMA · doi:10.1001/jama.2023.12618 · Cited by 93
Rising Mortality From Alcohol-Associated Liver Disease in the United States in the 21st Century
Moon, A. M., Yang, J. Y., Barritt, A. S., Bataller, R. A., & Peery, A. F. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000442 · Cited by 88
The CD38 glycohydrolase and the NAD sink: implications for pathological conditions
Zeidler, J. D., Hogan, K. A., Agorrody, G., Peclat, T., Kashyap, S., Kanamori, K. S., Gomez, L. S., Mazdeh, D. Z., Warner, G. M., Thompson, K. L., et al. (2022) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00451.2021 · Cited by 95
Irvine, K. M., Wockner, L. F., Shanker, M., Fagan, K. J., Horsfall, L. U., Fletcher, L. M., Ungerer, J. P. J., Pretorius, C. J., Miller, G. C., Clouston, A. D., et al. (2015) · Liver International · doi:10.1111/liv.12896 · Cited by 86
Singal, A. K., Arora, S. S., Wong, R. J., Satapathy, S. K., Shah, V. H., Kuo, Y., & Kamath, P. S. (2019) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000411 · Cited by 86
Substrate stiffness regulates primary hepatocyte functions
Natarajan, V., Berglund, E. J., Chen, D. X., & Kidambi, S. (2015) · RSC Advances · doi:10.1039/c5ra15208a · Cited by 84
Nutrition in Cirrhosis and Chronic Liver Disease
Juakiem, W. Y., Torres, D. M., & Harrison, S. A. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.09.004 · Cited by 83
Type 2 diabetes and risk of hospital admission or death for chronic liver diseases
Wild, S. H., Morling, J. R., McAllister, D., Kerssens, J., Fischbacher, C., Parkes, J., Roderick, P. J., Sattar, N. A., & Byrne, C. D. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.01.014 · Cited by 84
Axley, P. D., Ahmed, Z., Arora, S. S., Haas, A. M., Kuo, Y., Kamath, P. S., & Singal, A. K. (2019) · Liver Transplantation · doi:10.1002/lt.25443 · Cited by 76
Burden of liver disease in Brazil
Nader, L. A., de Mattos, Â. A., & Bastos, G. A. N. (2014) · Liver International · doi:10.1111/liv.12470 · Cited by 75
Global Disparities and Their Implications in the Occurrence and Outcome of Autoimmune Hepatitis
Czaja, A. J. (2017) · Digestive Diseases and Sciences · doi:10.1007/s10620-017-4675-y · Cited by 78
Hirode, G., Vittinghoff, E., & Wong, R. J. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05576-9 · Cited by 73
MELD‐GRAIL‐Na: Glomerular Filtration Rate and Mortality on Liver‐Transplant Waiting List
Asrani, S. K., Jennings, L. W., Kim, W. R., Kamath, P. S., Levitsky, J., Nadim, M. K., Testa, G., Leise, M. D., Trotter, J. F., & Klintmalm, G. B. (2019) · Hepatology · doi:10.1002/hep.30932 · Cited by 75
Self-citationMaran, B. A. V., Iqbal, M., Gangadaran, P., Ahn, B., Pasupuleti, V. R., & Shah, M. D. (2022) · Molecules · doi:10.3390/molecules27051533 · Cited by 76
Sarmast, N., Ogola, G., Kouznetsova, M., Leise, M., Bahirwani, R., Maiwall, R., Tapper, E., Trotter, J., Bajaj, J., Thacker, L., et al. (2020) · Hepatology · doi:10.1002/hep.31199 · Cited by 49
Self-citationMa, C., Qian, A. S., Nguyen, N. H., Stukalin, I., Congly, S. E., Shaheen, A. A., Swain, M. G., Teriaky, A., Asrani, S. K., & Singh, S. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001292 · Cited by 68
Self-citationAsrani, S. K., Jennings, L. W., Trotter, J. F., Levitsky, J., Nadim, M. K., Kim, W. R., Gonzalez, S. A., Fischbach, B. V., Bahirwani, R., Emmett, M., et al. (2018) · Hepatology · doi:10.1002/hep.30321 · Cited by 67
Self-citationWeeder, P. D., van Rijn, R., & Porte, R. J. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.03.008 · Cited by 67
Ahn, J. C., Attia, Z. I., Rattan, P., Mullan, A. F., Buryska, S. M., Allen, A. M., Kamath, P. S., Friedman, P. A., Shah, V. H., Noseworthy, P. A., et al. (2021) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001617 · Cited by 67
Mandorfer, M., Bota, S. I., Schwabl, P., Bucsics, T., Pfisterer, N., Summereder, C., Hagmann, M., Blacky, A., Ferlitsch, A., Sieghart, W., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110503 · Cited by 65
Organoids from adult liver and pancreas: Stem cell biology and biomedical utility
Hindley, C. J., Cordero-Espinoza, L., & Huch, M. (2016) · Developmental Biology · doi:10.1016/j.ydbio.2016.06.039 · Cited by 67
The potential of silymarin for the treatment of hepatic disorders
Hellerbrand, C., Schattenberg, J. M., Peterburs, P., Lechner, A., & Brignoli, R. (2016) · Clinical Phytoscience · doi:10.1186/s40816-016-0019-2 · Cited by 67
Understanding the Complexities of Cirrhosis
Muir, A. J. (2015) · Clinical Therapeutics · doi:10.1016/j.clinthera.2015.05.507 · Cited by 63
Variation Among United States Hospitals in Inpatient Mortality for Cirrhosis
Mellinger, J. L., Richardson, C. R., Mathur, A. K., & Volk, M. L. (2014) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.09.038 · Cited by 60
Paternostro, R., Wagner, D., Reiberger, T., Mandorfer, M., Schwarzer, R., Ferlitsch, M., Trauner, M. A., Peck‐Radosavljevic, M., & Ferlitsch, A. (2016) · Wiener klinische Wochenschrift · doi:10.1007/s00508-016-1127-1 · Cited by 60
The role of DNA damage and repair in liver cancer
Gillman, R., Floro, K. L., Wankell, M., & Hebbard, L. (2020) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2020.188493 · Cited by 57
Management of End-stage Liver Disease
Liou, I. W. (2013) · Medical Clinics of North America · doi:10.1016/j.mcna.2013.09.006 · Cited by 58
Simon, T. G., Kim, M. N., Luo, X., Yang, W., Ma, Y., Chong, D. Q., Fuchs, C. S., Meyerhardt, J. A., Corey, K. E., Chung, R. T., et al. (2020) · Journal of Hepatology · doi:10.1016/j.jhep.2019.12.022 · Cited by 57
Hospital readmissions in decompensated cirrhotics: Factors pointing toward a prevention strategy
Seraj, S. M., Campbell, E. J., Argyropoulos, S. K., Wegermann, K., Chung, R. T., & Richter, J. M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i37.6868 · Cited by 60
Is There a Potential Therapeutic Role for Caveolin-1 in Fibrosis?
Shihata, W., Putra, M. R. A., & Chin-Dusting, J. P. F. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00567 · Cited by 52
Trends in Chronic Liver Disease-Related Hospitalizations: A Population-Based Study
Asrani, S. K., Hall, L., Hagan, M. E., Sharma, S., Yeramaneni, S., Trotter, J. F., Talwalkar, J. A., & Kanwal, F. (2018) · The American Journal of Gastroenterology · doi:10.1038/s41395-018-0365-4 · Cited by 53
Self-citationMandorfer, M., Kozbial, K., Freissmuth, C., Schwabl, P., Stättermayer, A. F., Reiberger, T., Beinhardt, S., Schwarzer, R., Trauner, M. A., Ferlitsch, A., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13315 · Cited by 50
ACR Appropriateness Criteria ® Chronic Liver Disease
Horowitz, J. M., Kamel, I. R., Arif‐Tiwari, H., Asrani, S. K., Hindman, N. M., Kaur, H., McNamara, M. M., Noto, R. B., Qayyum, A., & Lalani, T. A. (2017) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2017.02.011 · Cited by 50
Self-citationSpontaneous bacterial peritonitis and extraperitoneal infections in patients with cirrhosis
de Mattos, Â. A., Wiltgen, D., Jotz, R. D. F., Dornelles, C. M. R., Fernandes, M. V., & de Mattos, Â. Z. (2020) · Annals of Hepatology · doi:10.1016/j.aohep.2020.04.010 · Cited by 51
Goldberg, D. S., Ross‐Driscoll, K., & Lynch, R. (2020) · Gastroenterology · doi:10.1053/j.gastro.2020.11.016 · Cited by 50
Therapeutic Potential and Nutraceutical Profiling of North Bornean Seaweeds: A Review
Shah, M. D., Maran, B. A. V., Shaleh, S. R. M., Zuldin, W. H., Gnanaraj, C., & Yong, Y. S. (2022) · Marine Drugs · doi:10.3390/md20020101 · Cited by 53
Ethnicity and the diagnosis gap in liver disease: a population-based study
Alazawi, W., Mathur, R., Abeysekera, K. W. M., Hull, S., Boomla, K., Robson, J. P., & Foster, G. R. (2014) · British Journal of General Practice · doi:10.3399/bjgp14x682273 · Cited by 49
Geographic Variability in Liver Disease-Related Mortality Rates in the United States
Desai, A. P., Mohan, P., Roubal, A. M., Bettencourt, R., & Loomba, R. S. (2018) · The American Journal of Medicine · doi:10.1016/j.amjmed.2018.01.047 · Cited by 48
Nonhospice Palliative Care Within the Treatment of End‐Stage Liver Disease
Verma, M., Tapper, E. B., Singal, A. G., & Navarro, V. J. (2020) · Hepatology · doi:10.1002/hep.31226 · Cited by 48
Ndugga, N., Lightbourne, T., Javaherian, K., Cabezas, J., Verma, N., Barritt, A. S., & Bataller, R. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-013620 · Cited by 47
Defining a Patient Population With Cirrhosis
Chang, E. K., Yu, C. Y., Clarke, R., Hackbarth, A. D., Sanders, T., Esrailian, E., Hommes, D. W., & Runyon, B. A. (2016) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000583 · Cited by 44
Mousa, N., Salah, M., Elbaz, S., Elmetwalli, A., Elhammady, A. M., Abdelkader, E., Abdelsalam, M., El‐Wakeel, N., Mansour, M., Hashem, M., et al. (2024) · Gut Pathogens · doi:10.1186/s13099-024-00610-2 · Cited by 42
Liver cirrhosis and cancer: comparison of mortality
Chung, W., Jo, C., Chung, W. J., & Kim, D. J. (2018) · Hepatology International · doi:10.1007/s12072-018-9850-5 · Cited by 43
Paik, J. M., Golabi, P., Younossi, Y., Saleh, N., Nhyira, A., & Younossi, Z. M. (2021) · Hepatology Communications · doi:10.1002/hep4.1673 · Cited by 42
Hepatic Fibrosis and Cirrhosis
Rockey, D. C. (2015) · Wiley eBooks · doi:10.1002/9781118512074.ch105 · Cited by 41
Hyperoside as a Potential Natural Product Targeting Oxidative Stress in Liver Diseases
Jang, E. (2022) · Antioxidants · doi:10.3390/antiox11081437 · Cited by 40
Mathew, R. P., & Venkatesh, S. K. (2018) · Current Gastroenterology Reports · doi:10.1007/s11894-018-0652-7 · Cited by 40
Lan, Y., Lu, Y., Li, J., Hu, S., Chen, S., Wang, Y., Yuan, X., Liu, H., Wang, X., Wu, S., et al. (2022) · Hepatology Communications · doi:10.1002/hep4.2081 · Cited by 37
Acute-On-Chronic Liver Failure
Asrani, S. K., & O’Leary, J. G. (2014) · Clinics in Liver Disease · doi:10.1016/j.cld.2014.05.004 · Cited by 39
Self-citationNoninvasive imaging assessment of portal hypertension
Kennedy, P., Bane, O., Hectors, S. J. C. G., Fischman, A. M., Schiano, T. D., Lewis, S. C., & Taouli, B. A. (2020) · Abdominal Radiology · doi:10.1007/s00261-020-02729-7 · Cited by 38
Gaetano, J. N. (2014) · Drug Healthcare and Patient Safety · doi:10.2147/dhps.s43304 · Cited by 37
Exercise-Induced Autophagy in Fatty Liver Disease
Chun, S. K., Lee, S., Yang, M., Leeuwenburgh, C., & Js, K. (2017) · Exercise and Sport Sciences Reviews · doi:10.1249/jes.0000000000000116 · Cited by 37
miR-223 represents a biomarker in acute and chronic liver injury
Schueller, F., Roy, S., Loosen, S. H., Alder, J., Koppe, C., Schneider, A. T., Wandrer, F., Bantel, H., Vucur, M., Mi, Q., et al. (2017) · Clinical Science · doi:10.1042/cs20170218 · Cited by 37
Zou, B., Yeo, Y. H., Jeong, D., Park, H., Sheen, E., Lee, D. H., Henry, L. L., García, G., Ingelsson, E., Cheung, R. C., et al. (2019) · Digestive Diseases and Sciences · doi:10.1007/s10620-019-05869-z · Cited by 38
Olfson, M., Cosgrove, C. M., Altekruse, S. F., Wall, M. M., & Blanco, C. (2021) · Health Affairs · doi:10.1377/hlthaff.2020.01573 · Cited by 37
Improving Quality of Health Care for Patients With Cirrhosis
Kanwal, F., Volk, M. L., Singal, A. G., Angeli, P., & Talwalkar, J. A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.10.029 · Cited by 36
Ghaoui, R., Friderici, J. L., Desilets, D. J., Lagu, T. C., Visintainer, P., Belo, A., Sotelo, J., & Lindenauer, P. K. (2014) · Journal of Hospital Medicine · doi:10.1002/jhm.2314 · Cited by 35
Metformin: update on mechanisms of action on liver diseases
Ruan, G., Wu, F., Shi, D., Sun, H., Wang, F., & Xu, C. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1327814 · Cited by 34
Hepatorenal Syndrome: A Review of Pathophysiology and Current Treatment Options
Erly, B. K., Carey, W. W., Kapoor, B. S., McKinney, J. M., Tam, M., & Wang, W. (2015) · Seminars in Interventional Radiology · doi:10.1055/s-0035-1564794 · Cited by 34
Access to Subspecialty Care And Survival Among Patients With Liver Disease
Mellinger, J. L., Moser, S., Welsh, D. E., Yosef, M., Van, T., McCurdy, H. M., Rakoski, M. O., Moseley, R. H., Glass, L. M., Waljee, A. K., et al. (2016) · The American Journal of Gastroenterology · doi:10.1038/ajg.2016.96 · Cited by 34
Development of an automated phenotyping algorithm for hepatorenal syndrome
Koola, J., Davis, S. E., Nimri, O. A., Parr, S. K., Fabbri, D., Malin, B., Ho, S. B., & Matheny, M. E. (2018) · Journal of Biomedical Informatics · doi:10.1016/j.jbi.2018.03.001 · Cited by 34
Shawon, S. I., Reyda, R. N., & Qais, N. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e25340 · Cited by 41
Burden of Cirrhosis on Patients and Caregivers
Volk, M. L. (2020) · Hepatology Communications · doi:10.1002/hep4.1526 · Cited by 35
Wang, P. L., Djerboua, M., & Flemming, J. A. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000194 · Cited by 34
ACR Appropriateness Criteria® Chronic Liver Disease
Bashir, M. R., Horowitz, J. M., Kamel, I. R., Arif‐Tiwari, H., Asrani, S. K., Chernyak, V., Goldstein, A. J., Grajo, J. R., Hindman, N. M., Kamaya, A., et al. (2020) · Journal of the American College of Radiology · doi:10.1016/j.jacr.2020.01.023 · Cited by 32
Self-citationPromising hepatoprotective effects of lycopene in different liver diseases
Ibrahim, I. M., Althagafy, H. S., Abd‐alhameed, E. K., Al-Thubiani, W. S., & Hassanein, E. H. M. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.121131 · Cited by 33
Non-invasive assessment of liver fibrosis and prognosis
Hagan, M. E., Asrani, S. K., & Talwalkar, J. A. (2015) · Expert Review of Gastroenterology & Hepatology · doi:10.1586/17474124.2015.1075391 · Cited by 32
Self-citationAdvances in Liver Regeneration: Revisiting Hepatic Stem/Progenitor Cells and Their Origin
Sadri, A.-R., Jeschke, M. G., & Amini‐Nik, S. (2015) · Stem Cells International · doi:10.1155/2016/7920897 · Cited by 33
Complications of Cirrhosis in Primary Care: Recognition and Management of Hepatic Encephalopathy
Flamm, S. L. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.06.008 · Cited by 33
The emergency medicine evaluation and management of the patient with cirrhosis
Long, B., & Koyfman, A. (2017) · The American Journal of Emergency Medicine · doi:10.1016/j.ajem.2017.12.047 · Cited by 31
Metadata
- Authors
- Asrani, S. K., Larson, J. J., Yawn, B., Therneau, T. M., & Kim, W. R.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Kim, W. Ray
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 145
- Issue
- 2
- Pages
- 375-382.e2
- ISSN
- 0016-5085 (ISSN-L)
- PMC
- PMC3890240
- OpenAlex
- W2079748214
- Cited by
- 311
- References
- 45
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 17 · 2023: 30 · 2022: 25 · 2021: 29 · 2020: 27 · 2019: 23 · 2018: 34 · 2017: 28 · 2016: 23 · 2015: 24 · 2014: 23 · 2013: 8
- FWCI
- 16.21
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (K24DK-92336, R01DK-34238, T32 DK07198)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease and Transplantation
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Keywords
- liver-related mortality, chronic liver disease, liver cirrhosis, mortality underestimation, cause of death classification, viral hepatitis, hepatobiliary cancer, hepatorenal syndrome, racial and ethnic disparities, Rochester Epidemiology Project
- MeSH terms
- Adult, Aged, Cause of Death, Female, Hepatic Encephalopathy, Hepatitis, Viral, Human, Carcinoma, Hepatocellular, Hepatorenal Syndrome, Humans, Liver Cirrhosis, Liver Diseases, Liver Neoplasms, Male, Middle Aged, Minnesota, National Center for Health Statistics, U.S., United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review